The Chicago Entrepreneur

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.

Previous post After a dementia diagnosis, getting Medicaid is ‘a beast.’ Here’s what to do.
Next post Sports streaming venture Venu priced at $42.99 a month